http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103356665-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85198bb655ba9bc3557b485e9a7df1fd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate | 2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44ec24e9be3be83fc485a71095833441 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_513a258af0a2419dccae76604f06a966 |
| publicationDate | 2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103356665-A |
| titleOfInvention | Application of new mangiferin to prevention and treatment of diabetic nephropathy |
| abstract | The invention provides an application of new mangiferin to prevention and treatment of diabetic nephropathy. A plurality of pharmacology experiments prove that the new mangiferin can correct redox unbalance, inhibit generation and aggregation of AGE (Advanced Glycation End Product), inhibit activity of a polyhydric alcohol loop and regulate lipid metabolism so as to resist development of diabetic nephropathy and improve the renal function. Therefore, the new mangiferin has a prospect of treating diabetic nephropathy. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107397754-A |
| priorityDate | 2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.